Aug 2026· Vaccine· Vol 91, pp.
129063
· 0 citations· 31 references
Medicine
TL;DR
Age showed the strongest association with uptake, peaking at 60-69 years, and foreign citizenship was associated with markedly lower uptake, while associations with sex and comorbidity were more modest.
Abstract
Pneumococcal vaccination is recommended for adults with diabetes because of their increased risk of pneumococcal disease, yet uptake remains suboptimal. This population-based retrospective cohort study assessed temporal patterns and factors associated with first recorded pneumococcal vaccination among adults with diabetes in the Romagna Local Health Authority, Italy, using linked administrative healthcare databases. We included 77,138 individuals (57,113 prevalent and 20,025 incident cases) followed through June 30, 2024. Monthly coverage was estimated using a person-time approach; time to vaccination and associated factors were examined using Kaplan-Meier, Cox, and competing-risks methods. Coverage increased from 7.2% in January 2017 to 28.0% in June 2024 but remained below 30%, with the largest monthly gains occurring during influenza vaccination seasons. In the incident cohort, the estimated cumulative probability of vaccination was 4.4% at one year, 12.6% at three years, and 34.8% at seven years, without a marked early increase after cohort entry. Age showed the strongest association with uptake, peaking at 60-69 years. Foreign citizenship was associated with markedly lower uptake, while associations with sex and comorbidity were more modest; comorbidity-related estimates were attenuated or reversed when death was treated as a competing event. Contextual factors showed limited associations. Recorded pneumococcal vaccination was low and delayed. The temporal pattern was compatible with incomplete integration into diabetes care pathways and suggested potential missed opportunities for timely vaccination, although the responsible mechanisms could not be distinguished. Systematic assessment at predefined healthcare contacts should be evaluated to reduce vaccination delays.
ABSTRACT Adults with diabetes mellitus are at increased risk of vaccine-preventable infections and complications. Despite recommendations for adult immunization, uptake remains suboptimal in many low- and middle-income countries, including the Philippines, where data remain limited. This cross-sectional study assessed...
Ranee Joy B. Jacobo, Michael L. Villa, Maria Jocelyn C. Isidro et al.· Human Vaccines & Immunothera...· 0 citations
Implementing PCV21 for at-risk and high-risk adults 18-64 years in Switzerland was predicted to avert 518 invasive pneumococcal disease cases, 12 post-meningitis sequelae cases, and 2,578 inpatient non-bacteremic pneumococcal pneumonia cases and 224 deaths.
Muloongo Simuzingili, Z. Yi, A. Favre-Bulle et al.· Journal of Medical Economics· 0 citations
Algorithm-based identification of chronic-disease populations linked to immunization registries enables scalable, risk-stratified monitoring applicable to any chronic-condition subgroup definable through administrative codes.
G. Frasca, Daniela Fortuna, C. Cintori et al.· Value in Health Regional Iss...· 0 citations
Ambulatory children with influenza who were vaccinated experienced less ILI symptom burden compared to those who were not vaccinated against influenza, but vaccination was not associated with symptom duration.
Amanda C Howa, Yu-Wei Zhu, T. McGonigle et al.· Clinical Infectious Diseases· 0 citations
Vaccination showed little or no association with ICU admission, but was associated with a one-quarter reduction in IHD among hospitalized older adults, reinforcing its benefits against fatal in-hospital outcomes.
Diogo F. P. Marques, Angela M. C. Rose, S. Monge et al.· Expert Review of Vaccines· 0 citations
BACKGROUND
The self-controlled case series (SCCS) design is widely used for short-term vaccine safety assessment but allows only indirect estimation of absolute risk differences. This study evaluated whether absolute measures should be estimated exclusively using cohort designs by comparing excess stroke incidence foll...
H. Chemaitelly, Naveed Akhtar, S. Al Jerdi et al.· Expert Review of Vaccines· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.